Loading...
Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
Patients with non-small cell lung cancer (NSCLC) can develop strong drug resistance following long-term treatment with platinum-based drugs. Increasing doses of chemotherapeutic drugs fail to obtain better results, and serious complications occur. It has been demonstrated that upregulation of excisi...
Saved in:
| Published in: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491090/ https://ncbi.nlm.nih.gov/pubmed/32963615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12072 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|